Antibody Science and Therapeutics explores the fascinating world of modern immunology, focusing on how antibodies—our body’s natural defence molecules—are designed, structured, and engineered to fight disease. This comprehensive course begins with the fundamental structure and biological functions of immunoglobulins, progressing to advanced concepts such as antibody gene organisation, recombination, and antibody diversity. You’ll gain a clear understanding of immunoglobulin classes (IgG, IgA, IgM, IgE, IgD) and their unique biological activities, as well as how antibodies interact with antigens to trigger immune responses through complement systems.

Learners will explore both classical and modern therapeutic approaches, including monoclonal antibody production, hybridoma technology, chimeric and humanised antibody engineering, and the emerging role of antibodies in cancer immunotherapy and viral diseases such as COVID-19. Through a balanced blend of theory and application, the course explains how biotechnology and molecular biology drive the development of life-saving antibody-based drugs and diagnostic tools.

By the end of the course, you’ll have gained valuable insights into antibody design, sequencing, and therapeutic engineering—skills that are highly relevant to modern biomedical research, biotechnology firms, and pharmaceutical innovation. Upon successful completion, learners receive a free course completion certificate, with premium certificate and transcript upgrades available for purchase. Students also benefit from 5-star rated, 24/7 email support, ensuring a smooth and rewarding learning experience.